• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Apimeds Pharmaceuticals US, Inc. (APUS)
	Q2-CY2026	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014
Balance Sheet Date		2026-Mar-31	2025-Dec-31	2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31
Fiscal Period		Q1-FY2026	Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024
Close Price of Common Stock	1.42$	1.73$	1.84$	1.80$	1.76$
Market Cap of Common Stock	21,429,471$	21,756,451$	23,139,809$	22,573,889$	20,373,730$
QoQ%	(1.50%)	(5.98%)	2.51%	10.80%
YoY%	5.18%
Common Shares Outstanding	15,091,177	12,575,983	12,575,983	12,575,983	12,575,983	3	7,903,850	7,903,850	7,903,850	7,903,850	7,903,850
QoQ%	20.00%	.00%	.00%	.00%	483,691,553.85%	(100.00%)	.00%	.00%	.00%	.00%
YoY%	20.00%	483,691,553.85%	59.11%	59.11%	59.11%	(100.00%)	.00%
Price to Sales
Price to Earnings	-	-	-	-	-
Price to Book	.17x	.17x	.15x	2.77x	2.09x
Total Revenue					9,518$
QoQ%
YoY%
TTM
TTM_QoQ%
TTM_YoY%
Gross Margin					100.00%
QoQ
YoY
Operating Income		(12,185,694$)	(7,040,051$)	(1,844,239$)	(2,663,904$)	(364,368$)	(275,613$)	(299,999$)	(427,757$)	(271,726$)
QoQ%		(73.09%)	(281.73%)	30.77%	(631.10%)	(32.20%)	8.13%	29.87%	(57.42%)
YoY%		(3,244.34%)	(2,454.33%)	(514.75%)	(522.76%)	(34.09%)
TTM		(23,733,888$)	(11,912,562$)	(5,148,124$)	(3,603,884$)	(1,367,737$)	(1,275,095$)
TTM_QoQ%		(99.23%)	(131.40%)	(42.85%)	(163.49%)	(7.27%)
TTM_YoY%		(1,635.27%)	(834.25%)
Operating Margin					(27,988.07%)
QoQ
YoY
Net Income		(35,059,852$)	(1,155,292$)	(1,781,255$)	(2,662,193$)	(402,397$)	(311,633$)	(332,521$)	(449,363$)	(296,473$)
QoQ%		(2,934.72%)	35.14%	33.09%	(561.58%)	(29.13%)	6.28%	26.00%	(51.57%)
YoY%		(8,612.75%)	(270.72%)	(435.68%)	(492.44%)	(35.73%)
TTM		(40,658,592$)	(6,001,137$)	(5,157,478$)	(3,708,744$)	(1,495,914$)	(1,389,990$)
TTM_QoQ%		(577.52%)	(16.36%)	(39.06%)	(147.93%)	(7.62%)
TTM_YoY%		(2,617.98%)	(331.74%)
Profit Margin					(27,970.09%)
QoQ
YoY
Equity to Common Shareholders		126,515,459$	153,347,827$	8,160,652$	9,737,679$	(1,760,518$)	(1,358,121$)	(1,046,488$)	(713,967$)	(264,604$)	31,869$
QoQ		(26,832,368$)	145,187,175$	(1,577,027$)	11,498,197$	(402,397$)	(311,633$)	(332,521$)	(449,363$)	(296,473$)
QoQ%		(17.50%)	1,779.11%	(16.20%)	653.11%	(29.63%)	(29.78%)	(46.57%)	(169.83%)	(930.29%)
YoY		128,275,977$	154,705,948$	9,207,140$	10,451,646$	(1,495,914$)	(1,389,990$)
YoY%		7,286.26%	11,391.18%	879.81%	1,463.88%	(565.34%)	(4,361.57%)
Dividends Paid
Additional Paid-In Capital QoQ		114,166$	146,267,697$	204,228$	14,113,669$	0$
Treasury Stock
QoQ
Goodwill
QoQ%
YoY%
Other Intangible Assets
QoQ
Amortization of Intangible Assets
Total Assets		141,219,157$	164,183,736$	9,250,036$	10,546,681$	259,904$	13,057$				422,076$
QoQ		(22,964,579$)	154,933,700$	(1,296,645$)	10,286,777$	246,847$
YoY		140,959,253$	164,170,679$				(409,019$)
Total Liabilities		14,703,698$	10,835,909$	1,089,384$	809,002$	2,020,422$	1,371,178$				390,207$
QoQ		3,867,789$	9,746,525$	280,382$	(1,211,420$)	649,244$
YoY		12,683,276$	9,464,731$				980,971$
Current Ratio		.90x	1.31x	8.34x	12.79x	.15x	.01x				3.42x
Total Current Assets		13,153,203$	13,983,859$	9,086,108$	10,349,549$	259,904$	13,057$				422,076$
QoQ		(830,656$)	4,897,751$	(1,263,441$)	10,089,645$	246,847$
Total Current Liabilities		14,584,883$	10,706,455$	1,089,384$	809,002$	1,770,422$	1,024,334$				123,316$
QoQ		3,878,428$	9,617,071$	280,382$	(961,420$)	746,088$
Debt to Asset Ratio		.10x	.07x	.12x	.08x	7.77x	105.01x				.92x
Long Term Debt
QoQ
YoY
Capital Lease Obligations			169,032$
Cash and Cash Equivalents		979,534$	1,636,655$	6,986,617$	8,735,323$	250,432$	3,455$				410,481$
QoQ		(657,121$)	(5,349,962$)	(1,748,706$)	8,484,891$	246,977$
YoY		729,102$	1,633,200$				(407,026$)
Interest Expenses
Interest Income		7$	35,919$	56,426$	15,247$	3$	30$	116$	517$	2,161$

Copy Table ✓